Publication Cover
Inhalation Toxicology
International Forum for Respiratory Research
Volume 15, 2003 - Issue 7
53
Views
27
CrossRef citations to date
0
Altmetric
Research Article

The Temporal Profile of Cytokines in the Bronchoalveolar Lavage Fluid in Mice Exposed to the Industrial Gas Phosgene

, , &
Pages 687-700 | Published online: 01 Oct 2008

  • Becher, R., Hetland, R. B., Refsnes, M., Dahl, J. E., Dalhman, H.J., and Schwarze, P. E. 2001. Rat lung responses after in vivo and in vitro exposure to various stone particles, lnhal. Toxicol. 13(9):789-805.
  • Bhalla, D. K., and Gupta, S. K. 2000. Lung injury, inflammation, and inflammatory stimuli in rats exposed to ozone. J. Toxicol. Environ. Health A 59:211-228.
  • Borak, J., and Diller, W. F. 2000. Phosgene exposure: Mechanisms of injury and treatment strategies.J. Occup. Environ. Med. 43:110-119.
  • Brett, J., Gerlach, H., Naworth, P., Steinberg, S., Godman, G., and Stern, D. 1989. Tumor necrosis fac-tor/cachectin increases permeability of endothelial cell monolayers by a mechanism involving reg-ulatory G proteins. J. Exp. Med. 168:1977-1991.
  • Burleson, G. R., and Keyes, L. L. 1989. Natural killer activity in Fischer-344 rat lungs as a method to assess pulmonary immunocompetence: lmmunosuppression by phosgene inhalation. lmmunopharmacol. Immunotoxicol 11:421-443.
  • Currie, W. D., Hatch, G. E., and Frosolono, M. F. 1987. Pulmonary alterations in rats due to phosgene inhalation. Fundam. Appl. Toxicol. 8:107-114.
  • Dechanet, J., Taupin, J. L., Chomarat, P., Rissoan, M. C., Moreau, J. F., Banchereau, J. and Miossec, P. 1994. lnterleukin-4 but not interleukin-10 inhibits production of leukemia inhibitory factor by rheumatoid synovium and synoviocytes. Eur/, lmmunol. 24:3222-3228.
  • Deshpande, A., Archuletta. D. C, Valdez, Y. E., Lehnert, N. M., Stavert, D. M., and Lehert, B. E. 1996. Tumor necrosis factor-a production by alveolar macrophages during the early development of phosgene-induced lung injury, lnhal. Toxicol. 8:65-80.
  • de Waal Malefyt, R., and Moore, K. 1998. Interleukinl O. In The cytokine handbook, 3rd ed., ed. A. Thomson, pp. 333-364. San Diego: Academic Press.
  • Donaldson, K., and Tran, C. L. 2002. Inflammation caused by particle and fibers, lnhal. Toxicol. 14(1): 5-27.
  • Duniho. S. M., Martin, J., Forster, J. S., Cascio, M. B., Moran, T. S., Carpin, L. B., and Sciuto, A. M. 2002. Acute pulmonary changes in mice exposed to phosgene. Toxicol. Pat hoi. 30(3):339-349.
  • Fan, J., Ye, R. D., and MaMk, A. B. 2001. Transcriptional mechanisms of acute lung injury. Am. J. Physiol. Lung Cell MoI. Physiol. 281:L1037-L1050.
  • Fukuda, N., Jayr, C., Lazrak, A., Wang, Y., Lucas, R., Matalon, S., and Matthay, M. A. 2001. Mecha-nisms of TNF-a stimulation of amiloride-sensitive sodium transport across alveolar epithelium. Am. J. Physiol. CeII MoI. Physiol. 280:L1258-L1265.
  • Gilchrist, H. L. 1933. The residual effects of warfare gases: The use of phosgene gas, with report of cases. Med. Bull. Vet. Admin. 10(1):1-36.
  • Goldman, M., Marchant, A., and Schandene, L. 1996. Endogenous interleukin-10 in inflammatory dis-orders: Regulatory roles and pharmacological modulation. In Cytokines and adhesion molecules in lung inflammation, eds. M. Chignard, M. Pretolani, P. Renesto, and B. Vargaftig. Ann. NY Acad. Sd. 796:283-293.
  • Henning, B., Goldblum, S. E., and McClain, C. J. 1987. lnterleukin-1 (IL-1) and tumor necrosis factor/ cachectin (TNF) increase endothelial permeability in vitro. J. Leukocyte Biol. 42:551-552.
  • Institute of Laboratory Animal Science. 1996. Guide for the care and use of laboratory animals. Washington, DC: National Research Council.
  • Johnston, C. J., Oberdörster, G., and Finkelstein, J. N. 2001. Recovery form oxidant-mediated lung injury: Response of metallothionein, MIP-2, and MCP-1 to nitrogen dioxide, oxygen, and ozone exposures, lnhal. Toxicol. 13(8):689-702.
  • Kelly, J. 1990. Cytokines in the lung. Am. Rev. Respir. Dis. 141:765-788.
  • Kienast, K., Knorst, M. Muller-Quernheim, J., and Ferlinz, R. 1996. Modulation of IL-1 ß, IL-6, IL-8, TNFa, and TGF-ß secretions by alveolar macrophages under NO2 exposure. Lung 174:57-67.
  • Kosmidou, I., Vassilakopoulos, T., Xagorari, A., Zakynthinos, S., Papapetropoulos, A., and Roussos, C. 2002. Production of interleukin-6 by skeletal myotubes: Role of reactive oxygen species. Am. J. Respir. Med. Crit. Care Med. 26:587-593.
  • Laskin, D. L., and Laskin, J. D. 1996. Macrophages, inflammatory mediators, and lung injury. Methods Companion Methods Enzymol. 10:61-70.
  • Li, X. Y., Donaldson, K., Brown, D., and MacNee, W. 1995. The role of tumor necrosis factor in in-creased airspace epithelial permeability in acute lung inflammation. Am. J. Respir. Cell MoI. Biol. 13:185-195.
  • Lund, K., Refsnes, M., Ramis, L, Dunster, J., Boe, J., Schwarze, P. E., Skovlund, E., Kelly, F. J., and Kongerud, J. 2002. Human exposure to hydrogen fluoride induces acute neutrophilic, eicosanoid, and antioxidant changes in nasal lavage fluid, lnhal. Toxicol. 14(2):119-132.
  • Pousset, F., Cremona, S., Dantzer, R., Kelley, K. W., and Parnet, P. 2001. IL-10 and IL-4 regulate type-l and type-lI IL-1 receptors expression in IL-1 ß-activated mouse primary astrocytes. J. Neurochem. 79:726-736.
  • Price, W. A., Moats-Staats, B., and Stiles, A. D. 2002. Pro- and anti-inflammatory cytokines regulate insulin-like growth factor binding protein production by fetal rat lung fibroblasts. Am J. Respir. Crit. Care Med. 26:283-289.
  • Rorison, D. G., and McPherson, S. J. 1992. Acute toxic inhalations. Emergency Med. Clinics North Am. 10(2):409-435.
  • Sato, E., Nelson, D. K., Koyama, S., Hoyt, J. C., and Robbins, R. A. 2001. Inflammatory cytokines mod-ulate eotaxin release by human lung fibroblast cell line. Exp. Lung Res. 27:173-183.
  • Sciuto, A. M., Lee, R., Forster, J., and Moran, T. 2002. Temporal changes in respiratory dynamics in mice exposed to phosgene, lnhal. Toxicol. 14:487-501.
  • Sciuto, A. M., Cascio, M. B., Moran, T. S., and Forster, J. S. 2003a. The fate of antioxidant enzymes in bronchoalveolar lavage fluid (BALF) over seven days in mice with acute lung injury. InHaI. Toxicol. 15(7):675-685.
  • Sciuto, A. M., Carpin, L. B., Moran, T. and Forster, J. S. 2003b. Chronological changes in electrolyte levels in arterial blood and BALF in mice after exposure to an edemagenic gas. lnhal. Toxicol. 15(7):663-674.
  • Shanley, T. P., Schmal, H., Freidl, H. P., Jones, M. L. and Ward, P. A. 1995. Regulatory effects of intrinsic IL-10 in IgG immune complex-induced lung injury. J. lmmunol. 154:3454-3460.
  • Speer, C. P. 1999. Inflammatory mechanisms in neonatal chronic lung disease, fur. J. Pediatr. 158: S18-S22.
  • Stricter, R. M., and Kunkel, S. L. 1994. Acute lung injury: The role of cytokines in the elicitation of neu-trophils.J. Invest. Med. 42:640-651.
  • Thomson, A. 1998. The cytokine handbook, 3rd ed., ed. A. Thomson. San Diego: Academic Press.
  • Thorne. P. S., McCray, P. B., Howe, T. S., and O'Neill, M. A. 1999. Early onset inflammatory responses in vitro to adenoviral vectors in the presence or absence of lipopolysaccharide-induced inflamma-tion. Am. I. Respir. Cell MoI. Biol. 20:1155-1164.
  • Vilcek, J. 1998. The cytokines: An overview. In The cytokine handbook, 3rd ed., ed. A. Thomson, pp. 1-22. San Diego: Academic Press.
  • Wegner, C. D., Gundel, R. H., Reilly, P., Haynes, N., Letts, L. G., and Rothlein, R. 1990. Intercellular adhesion molecule-1 (ICAM-1) in the pathogenesis of asthma. Science 247:456-459.
  • Whicher, J. T., and Evans, S. W. 1990. Cytokines in disease. Clin. Chem. 36(7):1269-1281.
  • Wuyts, A., Proost, P., and Van Damme, J. 1998. lnterleukin 8 and other CXC chemokines. In The cytokine handbook, 3rd ed., ed. A. Thomson, pp. 271-311. San Diego: Academic Press.
  • Xing, Z., Gauldie, J., Cox, G., Baumann, H., Jordana, M., Lei, X.-F., and Achong, M. K. 1998. IL-6 is an antiinflammatory cytokine required for controlling local or systemic acute inflammatory responses. J. Clin. Invest. 101:311-320.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.